Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas.
Although diabetes results in part from a deficiency of normal pancreatic beta cells, inducing human beta cells to regenerate is difficult. Reasoning that insulinomas hold the "genomic recipe" for beta cell expansion, we surveyed 38 human insulinomas to obtain insights into therapeutic pathways for beta cell regeneration. An integrative analysis of whole-exome and RNA-sequencing data was employed to extensively characterize the genomic and molecular landscape of insulinomas relative to normal beta cells. Here, we show at the pathway level that the majority of the insulinomas display mutations, copy number variants and/or dysregulation of epigenetic modifying genes, most prominently in the polycomb and trithorax families. Importantly, these processes are coupled to co-expression network modules associated with cell proliferation, revealing candidates for inducing beta cell regeneration. Validation of key computational predictions supports the concept that understanding the molecular complexity of insulinoma may be a valuable approach to diabetes drug discovery.Diabetes results in part from a deficiency of functional pancreatic beta cells. Here, the authors study the genomic and epigenetic landscapes of human insulinomas to gain insight into possible pathways for therapeutic beta cell regeneration, highlighting epigenetic genes and pathways.
Wang, H; Bender, A; Wang, P; Karakose, E; Inabnet, WB; Libutti, SK; Arnold, A; Lambertini, L; Stang, M; Chen, H; Kasai, Y; Mahajan, M; Kinoshita, Y; Fernandez-Ranvier, G; Becker, TC; Takane, KK; Walker, LA; Saul, S; Chen, R; Scott, DK; Ferrer, J; Antipin, Y; Donovan, M; Uzilov, AV; Reva, B; Schadt, EE; Losic, B; Argmann, C; Stewart, AF
Volume / Issue
Start / End Page
Pubmed Central ID
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)